How acetylcholine and sleep stages reshape brain wiring
CRCNS: Acetylcholine and state-dependent neural network reorganization
The team looks at how the brain chemical acetylcholine and the switching between wake, NREM, and REM sleep reshape brain circuits that support memory and mood, with possible relevance to autism.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11312719 on NIH RePORTER |
What this research studies
Researchers will combine brain recordings and computer network models to see how wake, NREM, and REM states change neuronal connections and signaling. They focus on how state-specific acetylcholine signaling and shifts in excitation/inhibition drive reorganization across the wake->NREM->REM cycle. The project uses experimental data (likely from animal models and electrophysiology) together with computational simulations to test how these dynamics support memory consolidation. Results aim to connect sleep‑stage biology to memory and affect, which may be relevant for autistic individuals with sleep or cognitive challenges.
Who could benefit from this research
Good fit: People with autistic disorder who experience sleep disturbances and related memory or emotional difficulties would be most relevant to this research.
Not a fit: People without sleep problems or whose condition does not involve sleep‑state or cholinergic signaling differences are less likely to see direct benefit from this work.
Why it matters
Potential benefit: If successful, this work could point to sleep-based or acetylcholine-targeted strategies to improve memory and emotional symptoms in people with autism.
How similar studies have performed: Previous animal and computational studies have linked acetylcholine and sleep stages to memory consolidation, but applying these ideas to whole‑network reorganization and autism is still emerging.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Zochowski, Michal R — University of Michigan at Ann Arbor
- Study coordinator: Zochowski, Michal R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.